Article

Updated Colorectal Cancer Screening Guidelines Highlight AJPB Week in Review

Author(s):

Top news of the week from The American Journal of Pharmacy Benefits.

5. Studies Recommend Addressing COPD Exacerbations to Improve Outcomes

Chronic obstructive pulmonary disease (COPD) patients may face various exacerbations that may affect their daily lives with the disease through symptoms. Read more.

4. Improved Interventions Needed to Decrease Pediatric Asthma-Related Hospital Readmissions

A new study evaluated which interventions were effective at the point of discharge from the hospital to prevent readmission. Read more.

3. Allergan Issues Recall of Taytulla Birth Control

Allergan has issued a voluntary recall in the United States for a single lot of its norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules (Taytulla) physician sample packs. Read more.

2. Patients with Hypertension Estimated to Have $2000 Annually, $131B Nationally in Costs

Those with hypertension had roughly 2.5 times more inpatient costs, almost twice the outpatient cost, and roughly triple the prescription medication cost annually. Read more.

1. ACS Now Recommends Colorectal Cancer Screening at Age 45

The American Cancer Society (ACS) has updated its colorectal cancer (CRC) screening guidelines to lower the age at which individuals are recommended to begin screening. Read more.

Related Videos
Image Credit: © peopleimages.com - stock.adobe.com
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Pharmacy technician working in a pharmacy -- Image credit: sofiko14 | stock.adobe.com
Team of pharmacists -- Image credit: Jacob Lund | stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards